Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126058321 | 12605832 | 1 | I | 20150922 | 20160725 | 20160729 | 20160729 | EXP | PHHY2016BR103959 | NOVARTIS | 88.97 | YR | F | Y | 0.00000 | 20160729 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126058321 | 12605832 | 1 | PS | ONBREZ BREEZHALER | INDACATEROL | 1 | Unknown | 150 UG, UNK | 22383 | 150 | UG | ||||||||
| 126058321 | 12605832 | 2 | SS | ENABLEX | DARIFENACIN HYDROBROMIDE | 1 | Unknown | 28 DF (28 TABLETS), UNK | U | 0 | 28 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126058321 | 12605832 | 1 | Chronic obstructive pulmonary disease |
| 126058321 | 12605832 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126058321 | 12605832 | OT |
| 126058321 | 12605832 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126058321 | 12605832 | Dementia Alzheimer's type | |
| 126058321 | 12605832 | Memory impairment | |
| 126058321 | 12605832 | Pneumonia | |
| 126058321 | 12605832 | Underweight |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |